ABSTRACT
The aim of this article is to gather 9 thought leaders and their team members to present their ideas about the future of in vitro fertilization and the andrology laboratory. Although we have seen much progress and innovation in the laboratory over the years, there is still much to come, and this article looks at what these leaders think will be important in the future development of technology and processes in the laboratory.
Subject(s)
Andrology/trends , Clinical Laboratory Services/trends , Fertilization in Vitro/trends , Infertility/therapy , Reproductive Medicine/trends , Andrology/legislation & jurisprudence , Automation, Laboratory , Clinical Laboratory Services/legislation & jurisprudence , Diffusion of Innovation , Female , Fertilization in Vitro/legislation & jurisprudence , Forecasting , History, 21st Century , Humans , Infertility/diagnosis , Infertility/physiopathology , Male , Policy Making , Pregnancy , Reproductive Medicine/legislation & jurisprudenceABSTRACT
In recent years there have been several Supreme Court adjudications concerning andrological issues. Among other things it was reconfirmed that drug therapy for erectile dysfunction does not have to be paid by compulsory health insurance providers. In contrast one Supreme Court decided that cryoconservation of ejaculates has to be paid by compulsory health insurance providers under certain circumstances.Vasectomy in men under guardianship is performed approximately 100 times per year in Germany. Before vasectomy is performed judicial authorisation has to be obtained in an extensive court proceeding.The Tissue Act regulates the implementation of the EG guideline 2004/23/EG into German law. This is only important for urologists who perform MESA/TESE procedures. Current case law does not allow use of the title Männerarzt as patients can confuse it with the official title andrologist.
